PUBBLICAZIONI e COMUNICAZIONI a congresso
- Lombardo L., Ravenda A., De Luca L., Marino Merlo F., Gitto R. A protocol for efficient database screening for new neuraminidase inhibitors as anti-flu therapeutics: from computational study to biological testing Conferenza INF-ACT 2025 – “Un passo più avanti” Napoli, 2-5 Aprile 2025.
- Lombardo L., Savoca G., Ravenda R., De Luca L., Marino Merlo F., Gitto R. Computational Modeling, Chemical Synthesis and Biological Evaluation of Compounds Targeting Viral Neuraminidase. “33rd Annual GP2A Medicinal Chemistry Conference, XIVth Paul Ehrlich MedChem Euro-PhD Network Meeting & COST Action OneHealthdrugs”, Nantes – France, 11th – 13th June 2025.
- Gitto R., Lombardo L., Ravenda A., Savoca G., Marino Merlo F., De Luca L. Uncovering new influenza neuraminidase inhibitors: rational design, synthesis, and biological evaluation of a series of new chemotypes XXIX National Meeting on Medicinal Chemistry, Parma – 14-17 settembre 2025
- De Luca L., Lombardo L., Ravenda A., Marino Merlo F., Gitto R. A Structure-Based workflow for designing Hemagglutinin stem inhibitors as broad-spectrum influenza therapeutics XXIX National Meeting on Medicinal Chemistry, Parma – 14-17 settembre 2025
Gitto R.*, Lombardo L., Ravenda A., Broccolo F, Mastino A., De Luca L, Marino-Merlo F.
Discovery of Influenza Neuraminidase Inhibitors: Structure-Based
Virtual Screening and Biological Evaluation of Novel Chemotypes ,
Virtual Screening and Biological Evaluation of Novel Chemotypes ,
Molecules 2025, 30(23), 4636; https://doi.org/10.3390/molecules30234636